AtHeart Medical is initiating a U.S. investigational device exemption trial for its atrial septal defects (ASD) occluder.
The reSept ASD Occluder is an occluder with a metal-free, bioresorbable frame. The implant is designed to overcome the limitations of occluders by reducing the risk of complications associated with the long-term presence of metal in the heart and to preserve future treatment options that require transseptal intervention.
Get the full story on our sister site, Medical Tubing + Extrusion.